Agilent Receives FDA Approval for Pediatric AEDs.html

[Guest guest]

Agilent Receives FDA Approval for Pediatric AEDs

Member Logon

Welcome

Not ?

Click Logout

Customer Service

Village Sponsors

Village Partners

EMS Institute of The Stamford Hospital

The Dragonfly Network

American Safety & Health Institute

Fairfield County Safekids

Home > Village Library > Village Library

Agilent Receives FDA Approval for Pediatric AEDs

Date: May 18, 2001

by: Agilent Technologies, Inc.

--------------------------------------------------------------------------

Innovative Pediatric Pads Enable Use of an AED to Save the Lives of the

Youngest Victims of Sudden Cardiac Arrest

PALO ALTO, Calif., May 3, 2001 -- Agilent Technologies Inc. (NYSE: A), the

leading worldwide manufacturer of automatic external defibrillators (AEDs),

today announced that it has become the first company to receive 510(k) clearance

from the Food and Drug Administration (FDA) to market its Heartstream FR2 AED

for use on children. The Heartstream FR2 AED, when equipped with specially

designed defibrillation pads, can be used on infants and children under age 8.

Sudden cardiac arrest, (SCA), is a leading cause of death in the United

States, striking approximately 225,000 Americans annually, including small

children. AEDs provide definitive treatment by delivering an electric shock to

the heart that can re-establish a regular heartbeat. However, to be effective,

the shock must be applied within the first few minutes following an arrest. AEDs

deliver a level of energy that is appropriate for adults. However, the American

Heart Association recommends lower levels of energy for children. As a result,

there have been dangerous treatment delays while waiting for specialized

equipment and trained personnel.

Anyone trained in CPR and the use of an AED can use the new pediatric pads

for the Heartstream FR2 AED. The pads employ an attenuator that reduces the

energy delivered by the AED to the appropriate dose for a child. A specially

developed pad connector represented by a pink teddy bear ensures that a

lay-responder can quickly identify proper pads for the victim in an emergency

situation.

" Minimally trained AED users could save many precious young lives with

easy-to-use technology that allows rapid delivery of defibrillation therapy to

infants and children, " said Dr. Dianne Atkins, associate professor of

pediatrics, University of Iowa College of Medicine. " I am grateful for the

tremendous national effort to place AEDs in the hands of first responders and in

public settings where large groups of people gather and where trained lay people

can respond. Now, we are able to extend this standard of care to our children. "

" We continue our mission to provide extremely easy-to-use products that

allow minimally trained responders to treat SCA victims safely and rapidly, "

said Deborah DiSanzo, vice president and general manager of Agilent's Cardiac

Resuscitation Division. " We are proud to make possible this level of care for

children and we applaud the FDA for sharing this commitment. "

The Heartstream FR2 AED, first introduced in May of 2000, is a

breakthrough in defibrillation technology that makes it practical for broad

groups of emergency first responders in communities, industrial settings, and

other public and private facilities to deliver time-critical defibrillation

therapy to victims of SCA. FR2 Pediatric pads are expected to be commercially

available in summer 2001.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global technology leader in

communications, electronics, life sciences and healthcare. With 48,000 employees

serving customers in more than 120 countries, Agilent had net revenue of $10.8

billion in fiscal year 2000. Information about Agilent can be found on the Web

at Agilent Technologies.

This site is a member of the Medical Banner Exchange

--------------------------------------------------------------------------

Home Terms & Conditions Privacy

Statement Site Info

© Copyright 2000 Vertical Villages, Inc. - All Rights Reserved

comments or suggestions?